Publications by authors named "C Pravadelli"

A 61-year-old man with alcoholic cirrhosis and a history of severe cholecystitis leading to secondary thrombosis of the recanalized paraumbilical vein was admitted to our hospital for recurrent gastrointestinal bleeding and severe anemia. Capsule endoscopy and CT angiography detected profuse bleeding in the proximal ileum from ectopic ileal varices. Hepatic venous-portal gradient (HVPG) measurement was consistent with severe portal hypertension.

View Article and Find Full Text PDF
Article Synopsis
  • Hepatitis C virus (HCV) affects about 1.1% of the global population, but in Italy, the infection rate among people who inject drugs (PWIDs) receiving treatment for substance use disorder is as high as 60%, complicated by factors like alcohol use, mental health issues, and homelessness.* -
  • A specialized, multidisciplinary team was created in Trento in October 2020 to provide antiviral treatment along with health education for HCV-positive PWIDs, utilizing Direct-Acting Antivirals and monitoring therapy completion, HCV eradication, and compliance.* -
  • Out of 40 enrolled patients, 100% completed their treatment regimen, with 92.5% achieving a sustained vi
View Article and Find Full Text PDF

Background And Study Aims: The coronavirus disease 2019 (COVID-19) represents a public health emergency of international concern, causing thousands of deaths worldwide. We performed a systematic review with meta-analysis in order to investigate the prevalence of COVID-19-induced liver injury.

Patients And Methods: We searched MEDLINE, Scopus, Web of Science and the Cochrane Library, for studies reporting laboratory data about COVID-19 patients, with last update on 25th March 2020.

View Article and Find Full Text PDF

Background: Radiofrequency ablation (RFA) and microwave ablation (MWA) represent the standard of care for patients with early hepatocellular carcinoma (HCC) who are unfit for surgery. The incidence of reported adverse events is low, ranging from 2.4% to 13.

View Article and Find Full Text PDF

Background: Evidence for the efficacy of radiation therapy for primary liver cancer is growing. In this context, proton therapy (PT) can potentially improve the therapeutic ratio, as demonstrated by recent clinical studies. Here we report the first European clinical experience on the use of PT for primary liver cancer.

View Article and Find Full Text PDF